Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
129
NCT01444118
A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients
Phase: Phase 3
Role: Lead Sponsor
Start: Nov 30, 2011
Completion: Dec 31, 2014
NCT02187367
Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients
Start: May 31, 2015
Completion: Sep 6, 2019
NCT03623750
E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C
Phase: Phase 1/2
Role: Collaborator
Start: Jul 6, 2018
Completion: Dec 14, 2021